Medicine Safety
When it comes to medicines, safety has many meanings and many stakeholders: Volunteers in clinical trials, researchers and technicians working in laboratories and manufacturing facilities, regulators at the Food and Drug Administration (FDA), physicians prescribing medicines, and patients who rely on those therapies to lead healthier, longer lives—all have vested interests in drug safety. The safety and integrity of medicines is critical to America’s biopharmaceutical industry and the patients we serve. Learn more about the key medical safety issues facing our industry today.
For a Healthier U.S.: Methods to Fight Prescription Abuse
80% of counterfeit drugs are produced overseas
Latest From The Blog
blog url
Bayh-Dole: The fuel for America’s innovation engine
September 2, 2026
ICYMI: Hospital consolidation is driving up health care costs
August 27, 2026
From lab to medicine cabinet: Following a medicine’s path to patients
August 24, 2026
What AARP isn’t telling seniors about MFN
August 24, 2026
It's time to modernize 340B: The case for a rebate model
August 19, 2026
Policymakers should improve patient access and reject price controls
August 18, 2026
CMS proposal could discourage patient-centered innovation
August 18, 2026
ICYMI: Biopharmaceutical companies in America hit new investment milestone
August 14, 2026
Insurers blame GLP-1s for rising costs. The data tells a different story.
August 14, 2026